Loading...
 

January - March 2017: 
Volume 30, Issue 1

Click on the image to download the Issue in PDF format.

ARCHIVE

The new ATS-ERS-JRS-ALAT Guidelines for diagnosis of Idiopathic Pulmonary Fibrosis (IPF)
Authors Information
First Department of Pneumonology, Interstitial Lung Disease Unit, Hospital for Diseases of the Chest ‘Sotiria’, Athens;  Medical School, National and Kapodistrian University of Athens, Greece
References
  1. Raghu G, Collard HR, Egan JJ, et al; ATS/ERS/JRS/ALAT Com-mittee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788–824.
  2. Travis WD, Costabel U, Hansell DM, et al. ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-48.
  3. Bouros D. Idiopathic interstitial pneumonias: Classification revision. Pneumon 2010, 23:359-62.
  4. Tzilas V, Bouros D. Usual interstitial pneumonia pattern in the diagnosis of idiopathic pulmonary fibrosis? Lancet Respir Med 2016;4:770-72.
  5. Tzouvelekis A, Tzilas V, Papiris S, Aidinis V, Bouros D. Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis: A patient’s “Q and A” approach. Pulm Pharmacol Ther 2017;42:21-4.
  6. Tzouvelekis A, Herazo-Maya J, Sakamoto K, Bouros D. Biomarkers in the Evaluation and Management of Idiopathic Pulmonary Fibrosis. Curr Top Med Chem 2016;16:1587-98.
  7. Bouros D, Tzouvelekis A. Idiopathic pulmonary fibrosis: on the move. Lancet Respir Med 2014;2:17-9.